New York State Common Retirement Fund’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Hold
0
-$1K 3491
2022
Q2
Sell
-7
Closed -$18.2K 3436
2022
Q1
$22K Hold
7
﹤0.01% 3281
2021
Q4
$43K Hold
7
﹤0.01% 3247
2021
Q3
$63K Sell
7
-10
-59% -$85.9K ﹤0.01% 3220
2021
Q2
$171K Buy
+17
New +$279K ﹤0.01% 3096

Other funds holding SEEL

New York State Common Retirement Fund's SEEL Position: Q3 2022 in Review

New York State Common Retirement Fund held its Seelos Therapeutics, Inc. Common Stock (SEEL) position steady in Q3 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3491.

New York State Common Retirement Fund first reported a position in SEEL in Q2 2021 and has held it in 4 quarters since. The position peaked at $171K in Q2 2021. 68 funds tracked by Wall St. Rank hold SEEL as of Q3 2022.

  • New York State Common Retirement Fund held 0 shares of Seelos Therapeutics, Inc. Common Stock worth $0 as of Q3 2022.
  • New York State Common Retirement Fund left its Seelos Therapeutics, Inc. Common Stock share count unchanged in Q3 2022.
  • Seelos Therapeutics, Inc. Common Stock made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q3 2022, its #3491 holding.
  • New York State Common Retirement Fund first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2021 and has held it in 4 quarters since.
  • New York State Common Retirement Fund's Seelos Therapeutics, Inc. Common Stock position peaked at $171K in Q2 2021.
  • 68 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.